These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 16254791)

  • 21. Phosphodiesterase 4 inhibitors as novel anti-inflammatory agents.
    Doherty AM
    Curr Opin Chem Biol; 1999 Aug; 3(4):466-73. PubMed ID: 10419856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AWD-12-281 (inhaled) (elbion/GlaxoSmithKline).
    Gutke HJ; Guse JH; Khobzaoui M; Renukappa-Gutke T; Burnet M
    Curr Opin Investig Drugs; 2005 Nov; 6(11):1149-58. PubMed ID: 16312137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of biological agents in immune-mediated inflammatory diseases.
    Efthimiou P; Markenson JA
    South Med J; 2005 Feb; 98(2):192-204. PubMed ID: 15759950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New drugs and treatment strategies for rheumatoid arthritis].
    Fantini F
    Recenti Prog Med; 2003 Sep; 94(9):361-79. PubMed ID: 12942798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitors of tumor necrosis factor for rheumatoid arthritis.
    Moreland LW
    J Rheumatol Suppl; 1999 May; 57():7-15. PubMed ID: 10328137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current management: Management of rheumatic diseases in the era of biological anti-rheumatic drugs.
    Konttinen YT; Seitsalo S; Lehto M; Santavirta S
    Acta Orthop; 2005 Oct; 76(5):614-9. PubMed ID: 16263606
    [No Abstract]   [Full Text] [Related]  

  • 27. Treating multiple sclerosis with natalizumab.
    Iaffaldano P; Lucchese G; Trojano M
    Expert Rev Neurother; 2011 Dec; 11(12):1683-92. PubMed ID: 22091593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Agents against cytokine synthesis or receptors.
    Yamagata T; Ichinose M
    Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases.
    Siebert S; Tsoukas A; Robertson J; McInnes I
    Pharmacol Rev; 2015; 67(2):280-309. PubMed ID: 25697599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anti-IL-6 : new therapeutic trends].
    Candil M; Zufferey P
    Rev Med Suisse; 2017 Jan; 13(544-545):105-109. PubMed ID: 28703549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natalizumab. Elan/Biogen.
    Elices MJ
    Curr Opin Investig Drugs; 2003 Nov; 4(11):1354-62. PubMed ID: 14758775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential role of pharmacogenetics in anti-TNF treatment of rheumatoid arthritis and Crohn's disease.
    Kooloos WM; de Jong DJ; Huizinga TW; Guchelaar HJ
    Drug Discov Today; 2007 Feb; 12(3-4):125-31. PubMed ID: 17275732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Monoclonal antibodies for the treatment of multiple sclerosis].
    Sánchez-Seco VG; Casanova Peño I; Arroyo González R
    Med Clin (Barc); 2014 Dec; 143 Suppl 3():30-4. PubMed ID: 25732947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment, management, and monitoring of established rheumatoid arthritis.
    Bingham CO; Miner MM
    J Fam Pract; 2007 Oct; 56(10 Suppl Rapid):S1-7; quiz S8. PubMed ID: 17949607
    [No Abstract]   [Full Text] [Related]  

  • 35. Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls.
    Silva LC; Ortigosa LC; Benard G
    Immunotherapy; 2010 Nov; 2(6):817-33. PubMed ID: 21091114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitaxin applied molecular evolution.
    Mikecz K
    Curr Opin Investig Drugs; 2000 Oct; 1(2):199-203. PubMed ID: 11249574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor necrosis factor inhibitors for rheumatoid arthritis.
    Scott DL; Kingsley GH
    N Engl J Med; 2006 Aug; 355(7):704-12. PubMed ID: 16914706
    [No Abstract]   [Full Text] [Related]  

  • 38. Recombinant human tumor necrosis factor receptor (p75) Fc fusion protein (TNFR:Fc) in rheumatoid arthritis.
    Murray KM; Dahl SL
    Ann Pharmacother; 1997 Nov; 31(11):1335-8. PubMed ID: 9391689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natalizumab for induction of remission in Crohn's disease.
    Macdonald JK; McDonald JW
    Cochrane Database Syst Rev; 2006 Jul; (3):CD006097. PubMed ID: 16856112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natalizumab: AN 100226, anti-4alpha integrin monoclonal antibody.
    Drugs R D; 2004; 5(2):102-7. PubMed ID: 15293871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.